Table 1

Characteristics of patients with rheumatoid arthritis (RA) using non-steroidal anti-inflammatory drugs (NSAIDs), who returned all three questionaires within one year. Comparison between high risk and low risk patients with RA. Results are shown as No (%)

Patients with RA, NSAID users
Low risk (n=515)High risk (n=731)Total 1246 (100%)Odds ratio (95% confidence interval)
Age <60 yearsAge ⩾60 years
Ulcer in medical history, No (%)Absent (A) 506 (41)Present (B) 48 (4)Absent (C) 570 (46)Present (D) 108 (9)
or 9 unknownor 5 unkown
Events1 (0.2)010 (1.8)5 (5)16 (1.3)10.8 (1.42 to 81.8)
 Ulcers1 (0.2)05 (0.9)2 (2)8 (0.6)4.97 (0.61 to 40.5)
 Complications0 (0)05 (0.9)3 (3)8 (0.6)p<0.05
Gastroprotection149 (29)26 (54)249 (44)79 (73)5081-151 (41)1.66 (1.42 to 1.93)
GI complaints1-150
 Epigastric pain61 (12)11 (23)47 (9)17 (16)0.85 (0.60 to 1.22)
 Heartburn62 (12)7 (15)47 (9)22 (20)0.82 (0.58 to 1.18)
 Nausea52 (10)6 (13)31 (6)9 (8)0.60 (0.40 to 0.90)
 Vomiting14 (3)3 (6)11 (2)5 (5)0.96 (0.47 to 1.92)
 Belching60 (12)11 (23)56 (10)18 (17)1.00 (0.70 to 1.42)
 Puffy feeling in the stomach66 (13)16 (33)52 (9)14 (13)0.86 (0.61 to 1.21)
Current treatment
 DMARDs1-150 424 (84)38 (79)408 (72)67 (62)944 (76)0.62 (0.47 to 0.82)
 Corticosteroids74 (15)9 (19)111 (20)25 (23)219 (18)1.47 (1.09 to 2.00)
 Anticoagulants8 (2)014 (3)6 (6)28 (2)1.78 (0.78 to 3.92)
 Cardiovascular drugs66 (13)10 (21)149 (26)37 (34)263 (21)2.49 (1.84 to 3.38)
  • 1-150 GI = gastrointestinal complaints: moderate, severe, or very severe (versus absent or mild); DMARDs = disease modifying antirheumatic drugs.

  • 1-151 For five patients it was unknown whether or not they were treated with gastroprotection.